Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
NCT ID: NCT03328065
Last Updated: 2022-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
36 participants
OBSERVATIONAL
2017-12-19
2020-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
NCT05447611
Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
NCT02015923
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
NCT04415190
Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive Cancer
NCT02956876
Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
NCT02363049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable patients, early responders to treatment and caregivers
Interviews
Semi-directed interviews, recorded and transcribed for analysis
Questionnaires
economic and psycho-social questionnaires
Stable patients and intermediate responders and c
Stable patients and intermediate responders to treatments and caregivers
Interviews
Semi-directed interviews, recorded and transcribed for analysis
Questionnaires
economic and psycho-social questionnaires
Doctors
Interviews
Semi-directed interviews, recorded and transcribed for analysis
Questionnaires
economic and psycho-social questionnaires
Patients in therapeutic escape and their caregivers
Interviews
Semi-directed interviews, recorded and transcribed for analysis
Questionnaires
economic and psycho-social questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interviews
Semi-directed interviews, recorded and transcribed for analysis
Questionnaires
economic and psycho-social questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men or women
* who have been informed about the study
* and who have provided verbal consent to take part in the study
* able to understand written and spoken French
* with non-resectable metastatic cancer of: the colon, or the rectosigmoid junction or the stomach or bile ducts or rectum or gastrointestinal neuroendocrine tumor or lung (not small-cell cancer) or pancreas
* with a caregiver designated as the principal caregiver (family, friend, neighbour)
* who has consented to the principal caregiver taking part in a qualitative interview
* able to take part in an interview lasting roughly one hour
II- CAREGIVERS
* men or women
* who have been informed about the study
* who have provided verbal consent to take part in the study
* able to understand written and spoken French
* able to follow an interview lasting roughly one hour
III-DOCTORS
* men or women
* who have been informed about the study
* who have provided verbal consent to take part in the study
* specialised in specific organ or oncologist prescriber
Exclusion Criteria
* under guardianship or ward of court
* with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis, severe mental retardation etc.)
II- CAREGIVERS
* under guardianship or ward of court,
* with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis…),
* with severe mental retardation impairing ability to understand.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEJEUNE FdF 2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.